Practical recommendations for the allergological risk assessment of the COVID-19 vaccination – a harmonized statement of allergy centers in Germany

Margitta Worm; Andrea Bauer; Bettina Wedi; Regina Treudler; Wolfgang Pfuetzner; Knut Brockow; Timo Buhl; Torsten Zuberbier; Joachim Fluhr; Gerda Wurpts; Ludger Klimek; Thilo Jakob; Hans F. Merk; Norbert Mülleneisen; Stefani Roeseler; Heinrich Dickel; Ulrike Raap; Jörg Kleine-Tebbe

doi:10.5414/ALX02225E

Practical recommendations for the allergological risk assessment of the COVID-19 vaccination – a harmonized statement of allergy centers in Germany

Margitta Worm
, Andrea Bauer
, Bettina Wedi
, Regina Treudler
, Wolfgang Pfuetzner
, Knut Brockow
, Timo Buhl
, Torsten Zuberbier
, Joachim Fluhr
, Gerda Wurpts
, Ludger Klimek
, Thilo Jakob
, Hans F. Merk
, Norbert Mülleneisen
, Stefani Roeseler
, Heinrich Dickel
, Ulrike Raap
, Jörg Kleine-Tebbe

Department of Dermatology and Allergology

Research output: Contribution to journal › Article › peer-review

27 Scopus citations

Abstract

Severe allergic reactions to vaccines are very rare. Single severe reactions have occurred worldwide after vaccination with the new mRNA-based COVID-19 vaccines. PEG2000 is discussed as a possible trigger. We provide guidance on risk assessment regarding COVID-19 vaccination in patients with allergic diseases and suggest a standardized, resource-oriented diagnostic and therapeutic procedure. Reports of severe allergic reactions in the context of COVID-19 vaccination can be made via www.anaphylaxie.net using an online questionnaire.

Original language	English
Pages (from-to)	72-76
Number of pages	5
Journal	Allergologie Select
Volume	5
DOIs	https://doi.org/10.5414/ALX02225E
State	Published - 2021

Keywords

COVID-19 vaccination
allergy
anaphylaxis
polyethylene glycol
polysorbate 80
skin test

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.5414/ALX02225E

Cite this

Worm, M., Bauer, A., Wedi, B., Treudler, R., Pfuetzner, W., Brockow, K., Buhl, T., Zuberbier, T., Fluhr, J., Wurpts, G., Klimek, L., Jakob, T., Merk, H. F., Mülleneisen, N., Roeseler, S., Dickel, H., Raap, U., & Kleine-Tebbe, J. (2021). Practical recommendations for the allergological risk assessment of the COVID-19 vaccination – a harmonized statement of allergy centers in Germany. Allergologie Select, 5, 72-76. https://doi.org/10.5414/ALX02225E

@article{47ee21a8d87d4ccd85c6f8cdcbb2b352,

title = "Practical recommendations for the allergological risk assessment of the COVID-19 vaccination – a harmonized statement of allergy centers in Germany",

abstract = "Severe allergic reactions to vaccines are very rare. Single severe reactions have occurred worldwide after vaccination with the new mRNA-based COVID-19 vaccines. PEG2000 is discussed as a possible trigger. We provide guidance on risk assessment regarding COVID-19 vaccination in patients with allergic diseases and suggest a standardized, resource-oriented diagnostic and therapeutic procedure. Reports of severe allergic reactions in the context of COVID-19 vaccination can be made via www.anaphylaxie.net using an online questionnaire.",

keywords = "COVID-19 vaccination, allergy, anaphylaxis, polyethylene glycol, polysorbate 80, skin test",

author = "Margitta Worm and Andrea Bauer and Bettina Wedi and Regina Treudler and Wolfgang Pfuetzner and Knut Brockow and Timo Buhl and Torsten Zuberbier and Joachim Fluhr and Gerda Wurpts and Ludger Klimek and Thilo Jakob and Merk, \{Hans F.\} and Norbert M{\"u}lleneisen and Stefani Roeseler and Heinrich Dickel and Ulrike Raap and J{\"o}rg Kleine-Tebbe",

note = "Publisher Copyright: {\textcopyright} 2021 Dustri-Verlag Dr. K. Feistle.",

year = "2021",

doi = "10.5414/ALX02225E",

language = "English",

volume = "5",

pages = "72--76",

journal = "Allergologie Select",

issn = "2512-8957",

}

Worm, M, Bauer, A, Wedi, B, Treudler, R, Pfuetzner, W, Brockow, K, Buhl, T, Zuberbier, T, Fluhr, J, Wurpts, G, Klimek, L, Jakob, T, Merk, HF, Mülleneisen, N, Roeseler, S, Dickel, H, Raap, U & Kleine-Tebbe, J 2021, 'Practical recommendations for the allergological risk assessment of the COVID-19 vaccination – a harmonized statement of allergy centers in Germany', Allergologie Select, vol. 5, pp. 72-76. https://doi.org/10.5414/ALX02225E

TY - JOUR

T1 - Practical recommendations for the allergological risk assessment of the COVID-19 vaccination – a harmonized statement of allergy centers in Germany

AU - Worm, Margitta

AU - Bauer, Andrea

AU - Wedi, Bettina

AU - Treudler, Regina

AU - Pfuetzner, Wolfgang

AU - Brockow, Knut

AU - Buhl, Timo

AU - Zuberbier, Torsten

AU - Fluhr, Joachim

AU - Wurpts, Gerda

AU - Klimek, Ludger

AU - Jakob, Thilo

AU - Merk, Hans F.

AU - Mülleneisen, Norbert

AU - Roeseler, Stefani

AU - Dickel, Heinrich

AU - Raap, Ulrike

AU - Kleine-Tebbe, Jörg

PY - 2021

Y1 - 2021

N2 - Severe allergic reactions to vaccines are very rare. Single severe reactions have occurred worldwide after vaccination with the new mRNA-based COVID-19 vaccines. PEG2000 is discussed as a possible trigger. We provide guidance on risk assessment regarding COVID-19 vaccination in patients with allergic diseases and suggest a standardized, resource-oriented diagnostic and therapeutic procedure. Reports of severe allergic reactions in the context of COVID-19 vaccination can be made via www.anaphylaxie.net using an online questionnaire.

AB - Severe allergic reactions to vaccines are very rare. Single severe reactions have occurred worldwide after vaccination with the new mRNA-based COVID-19 vaccines. PEG2000 is discussed as a possible trigger. We provide guidance on risk assessment regarding COVID-19 vaccination in patients with allergic diseases and suggest a standardized, resource-oriented diagnostic and therapeutic procedure. Reports of severe allergic reactions in the context of COVID-19 vaccination can be made via www.anaphylaxie.net using an online questionnaire.

KW - COVID-19 vaccination

KW - allergy

KW - anaphylaxis

KW - polyethylene glycol

KW - polysorbate 80

KW - skin test

UR - https://www.scopus.com/pages/publications/105026379165

U2 - 10.5414/ALX02225E

DO - 10.5414/ALX02225E

M3 - Article

AN - SCOPUS:105026379165

SN - 2512-8957

VL - 5

SP - 72

EP - 76

JO - Allergologie Select

JF - Allergologie Select

ER -

Practical recommendations for the allergological risk assessment of the COVID-19 vaccination – a harmonized statement of allergy centers in Germany

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this